HUT73790A - Carbazole derivatives, pharmaceutical compositions containing them and process for proucing them - Google Patents
Carbazole derivatives, pharmaceutical compositions containing them and process for proucing them Download PDFInfo
- Publication number
- HUT73790A HUT73790A HU9503321A HU9503321A HUT73790A HU T73790 A HUT73790 A HU T73790A HU 9503321 A HU9503321 A HU 9503321A HU 9503321 A HU9503321 A HU 9503321A HU T73790 A HUT73790 A HU T73790A
- Authority
- HU
- Hungary
- Prior art keywords
- fluoro
- compound
- carbazole
- formula
- ylmethyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB939310635A GB9310635D0 (en) | 1993-05-21 | 1993-05-21 | Chemical compounds |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HU9503321D0 HU9503321D0 (en) | 1996-01-29 |
| HUT73790A true HUT73790A (en) | 1996-09-30 |
Family
ID=10736007
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU9503321A HUT73790A (en) | 1993-05-21 | 1994-05-19 | Carbazole derivatives, pharmaceutical compositions containing them and process for proucing them |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0699196A1 (fr) |
| JP (1) | JPH08510455A (fr) |
| CN (1) | CN1126473A (fr) |
| AU (1) | AU6928794A (fr) |
| BG (1) | BG100154A (fr) |
| CA (1) | CA2162921A1 (fr) |
| CZ (1) | CZ305195A3 (fr) |
| FI (1) | FI955587A (fr) |
| GB (1) | GB9310635D0 (fr) |
| HU (1) | HUT73790A (fr) |
| IL (1) | IL109703A0 (fr) |
| NO (1) | NO954681D0 (fr) |
| OA (1) | OA10195A (fr) |
| PE (1) | PE31195A1 (fr) |
| PL (1) | PL311702A1 (fr) |
| SK (1) | SK142495A3 (fr) |
| TW (1) | TW279866B (fr) |
| WO (1) | WO1994027989A1 (fr) |
| ZA (1) | ZA943494B (fr) |
Families Citing this family (26)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUT75871A (en) * | 1993-09-30 | 1997-05-28 | Yamanouchi Co | Azole derivatives and pharmaceutical compositions thereof |
| AU3846395A (en) * | 1994-11-07 | 1996-05-31 | Janssen Pharmaceutica N.V. | Compositions comprising carbazoles and cyclodextrins |
| CN1177350A (zh) * | 1995-03-01 | 1998-03-25 | 山之内制药株式会社 | 咪唑衍生物及其药学组合物 |
| CN1251577A (zh) * | 1997-02-21 | 2000-04-26 | 武田药品工业株式会社 | 稠环化合物及其生产和应用 |
| CN100572363C (zh) | 2000-11-17 | 2009-12-23 | 武田药品工业株式会社 | 咪唑衍生物、其制备方法及其用途 |
| ATE502030T1 (de) | 2000-11-20 | 2011-04-15 | Takeda Pharmaceutical | Imidazolderivate, verfahren zu deren herstellung und deren verwendung |
| DE60139639D1 (de) | 2000-12-08 | 2009-10-01 | Takeda Pharmaceutical | Substituierte thiazolderivate mit 3-pyridylgruppen, verfahren zu deren herstellung und deren verwendung |
| EP1902026B1 (fr) | 2005-06-24 | 2010-02-17 | Eli Lilly And Company | Derives tetrahydrocarbazole convenant comme modulateurs du recepteur d'angrogene |
| US8093279B2 (en) | 2005-12-13 | 2012-01-10 | Gillian Reed, legal representative | Compound |
| GB0525323D0 (en) * | 2005-12-13 | 2006-01-18 | Sterix Ltd | Compound |
| CN100586932C (zh) * | 2007-01-26 | 2010-02-03 | 中国医学科学院医药生物技术研究所 | 抗肿瘤化合物及其制备方法 |
| UA105794C2 (uk) | 2009-06-26 | 2014-06-25 | Новартіс Аг | 1,3-ДИЗАМІЩЕНІ ПОХІДНІ ІМІДАЗОЛІДИН-2-ОНУ ЯК ІНГІБІТОРИ Cyp17 |
| AU2011212813B2 (en) * | 2010-02-04 | 2014-10-23 | Radius Health, Inc. | Selective androgen receptor modulators |
| ME02474B (fr) | 2010-05-12 | 2017-02-20 | Radius Health Inc | Schémas thérapeutiques |
| US9132105B2 (en) | 2010-08-04 | 2015-09-15 | Pellficure Pharmaceuticals, Inc. | Treatment of prostate carcinoma |
| US8946260B2 (en) | 2010-09-16 | 2015-02-03 | Novartis Ag | 17α-hydroxylase/C17,20-lyase inhibitors |
| EP2621901B1 (fr) | 2010-09-28 | 2015-07-29 | Radius Health, Inc | Modulateurs selectifs des récepteurs d'androgen |
| ES2656218T3 (es) | 2011-04-28 | 2018-02-26 | Novartis Ag | Inhibidores de 17 alfa-hidroxilasa/C17,20-liasa |
| US9492460B2 (en) * | 2013-02-27 | 2016-11-15 | Bristol-Myers Squibb Company | Carbazole compounds useful as bromodomain inhibitors |
| CA2902335C (fr) | 2013-03-14 | 2021-09-14 | Pellficure Pharmaceuticals, Inc. | Nouvelle therapie pour le carcinome de la prostate |
| US9421264B2 (en) | 2014-03-28 | 2016-08-23 | Duke University | Method of treating cancer using selective estrogen receptor modulators |
| DK3122426T3 (da) | 2014-03-28 | 2023-04-03 | Univ Duke | Behandling af brystcancer ved anvendelse af selektive østrogenreceptormodulatorer |
| US10093620B2 (en) | 2014-09-12 | 2018-10-09 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
| LT3474841T (lt) | 2016-06-22 | 2022-06-10 | Ellipses Pharma Ltd | Ar+ krūties vėžio gydymo būdai |
| EP3528799A1 (fr) | 2016-10-24 | 2019-08-28 | Pellficure Pharmaceuticals, Inc. | Compositions pharmaceutiques de 5-hydroxy-2-méthylnaphtalène-1, 4-dione |
| PL3565542T3 (pl) | 2017-01-05 | 2024-07-29 | Radius Pharmaceuticals, Inc. | Postacie polimorficzne rad1901-2hcl |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CS229934B2 (en) * | 1981-07-07 | 1984-07-16 | Pfizer | Production method subst.indolylacryte acid derivative |
| GB8518743D0 (en) * | 1985-07-24 | 1985-08-29 | Glaxo Group Ltd | Heterocyclic compounds |
-
1993
- 1993-05-21 GB GB939310635A patent/GB9310635D0/en active Pending
-
1994
- 1994-05-02 ZA ZA943494A patent/ZA943494B/xx unknown
- 1994-05-17 TW TW083104441A patent/TW279866B/zh active
- 1994-05-19 EP EP94917647A patent/EP0699196A1/fr not_active Withdrawn
- 1994-05-19 CZ CZ953051A patent/CZ305195A3/cs unknown
- 1994-05-19 CN CN94192683A patent/CN1126473A/zh active Pending
- 1994-05-19 WO PCT/EP1994/001613 patent/WO1994027989A1/fr not_active Application Discontinuation
- 1994-05-19 AU AU69287/94A patent/AU6928794A/en not_active Abandoned
- 1994-05-19 JP JP7500181A patent/JPH08510455A/ja active Pending
- 1994-05-19 SK SK1424-95A patent/SK142495A3/sk unknown
- 1994-05-19 PL PL94311702A patent/PL311702A1/xx unknown
- 1994-05-19 HU HU9503321A patent/HUT73790A/hu unknown
- 1994-05-19 CA CA002162921A patent/CA2162921A1/fr not_active Abandoned
- 1994-05-20 IL IL10970394A patent/IL109703A0/xx unknown
- 1994-11-18 PE PE1994255110A patent/PE31195A1/es not_active Application Discontinuation
-
1995
- 1995-11-17 OA OA60742A patent/OA10195A/en unknown
- 1995-11-20 NO NO954681A patent/NO954681D0/no unknown
- 1995-11-20 FI FI955587A patent/FI955587A/fi not_active Application Discontinuation
- 1995-11-21 BG BG100154A patent/BG100154A/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BG100154A (en) | 1996-07-31 |
| TW279866B (fr) | 1996-07-01 |
| OA10195A (en) | 1996-12-18 |
| PE31195A1 (es) | 1995-10-18 |
| AU6928794A (en) | 1994-12-20 |
| PL311702A1 (en) | 1996-03-04 |
| CN1126473A (zh) | 1996-07-10 |
| ZA943494B (en) | 1995-01-23 |
| FI955587A0 (fi) | 1995-11-20 |
| NO954681L (no) | 1995-11-20 |
| GB9310635D0 (en) | 1993-07-07 |
| JPH08510455A (ja) | 1996-11-05 |
| EP0699196A1 (fr) | 1996-03-06 |
| IL109703A0 (en) | 1994-08-26 |
| FI955587A (fi) | 1995-11-20 |
| WO1994027989A1 (fr) | 1994-12-08 |
| SK142495A3 (en) | 1996-06-05 |
| NO954681D0 (no) | 1995-11-20 |
| CZ305195A3 (en) | 1996-06-12 |
| CA2162921A1 (fr) | 1994-12-08 |
| HU9503321D0 (en) | 1996-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUT73790A (en) | Carbazole derivatives, pharmaceutical compositions containing them and process for proucing them | |
| JP6367822B2 (ja) | Ｅｐ４アンタゴニストとしての新規ベンゾイミダゾール誘導体 | |
| KR930005994B1 (ko) | 4-치환된 안드로스텐디온 유도체의 제조방법 | |
| BE1001004A4 (fr) | Nouvelles cetones tricycliques utiles comme medicaments, procede et intermediaires pour leur preparation. | |
| EP1432698A2 (fr) | 3-pyridyl indoles et indazoles substitues servant d'inhibiteurs de c17,20 lyase | |
| JP2000511532A (ja) | 性腺刺激ホルモン放出ホルモンのアンタゴニスト | |
| JPH08512299A (ja) | ５ｈｔ▲下２ｃ▼アンタゴニストとしてのインドリン誘導体 | |
| JP2000511182A (ja) | 性腺刺激ホルモン放出ホルモンのアンタゴニスト | |
| JP4119246B2 (ja) | エストロゲンレセプター修飾物質 | |
| WO1997000257A1 (fr) | Derives d'imidazole fusionnes et composition medicinale les contenant | |
| US6159959A (en) | Combined estrogen and antiestrogen therapy | |
| US5578630A (en) | Heterocyclic compounds which inhibit aromatase | |
| US7488743B2 (en) | Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof | |
| PL182956B1 (pl) | Nowy związek, pochodna 6-{triazolilo[3-(trifluorometylo)-fenylo]metylo}-2-chinolinonu i-chinolinotionu, kompozycja farmaceutyczna, nowy związek, pochodna 6-{triazolilo[3-(trifluorometylo)-fenylo]metylo}-2-chinoliny i sposób wytwarzania 6-{triazolilo[3-(trifluorometylo)-fenylo]metylo}-2-chinoliny | |
| JPH0113475B2 (fr) | ||
| JPS6112668A (ja) | ピラゾール化合物 | |
| EP1283208A1 (fr) | Nouveaux derives de benzofurane | |
| JP6470984B2 (ja) | アロマターゼ阻害剤及びこれを含む医薬 | |
| EP3774802B1 (fr) | Composés et procédés pour la protéolyse sélective de récepteurs de glucocorticoïdes | |
| JP2003518112A (ja) | 置換型ピロール | |
| EP0574992A1 (fr) | Dérivés de 5(1,2,4-triazol-1-ylméthyl)-3H-isobenzofuran-1-one, leurs préparation et application en tant qu'inhibiteurs d'aromatase | |
| HU199142B (en) | Process for producing tricyclic ketones and pharmaceutical compositions comprising same as active ingredient | |
| JP2003531142A (ja) | Ｒａｓファルネシルトランスフェラーゼのジヒドロ−２Ｈ−ナフタレン−１−オン阻害剤 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| DFC4 | Cancellation of temporary protection due to refusal |